Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Tick-borne encephalitis: A comprehensive review of the epidemiology, virology, and clinical picture

G. Chiffi, D. Grandgirard, SL. Leib, A. Chrdle, D. Růžek

. 2023 ; 33 (5) : e2470. [pub] 20230701

Language English Country England, Great Britain

Document type Journal Article, Review, Research Support, Non-U.S. Gov't

Tick-borne encephalitis virus (TBEV) is a flavivirus commonly found in at least 27 European and Asian countries. It is an emerging public health problem, with steadily increasing case numbers over recent decades. Tick-borne encephalitis virus affects between 10,000 and 15,000 patients annually. Infection occurs through the bite of an infected tick and, much less commonly, through infected milk consumption or aerosols. The TBEV genome comprises a positive-sense single-stranded RNA molecule of ∼11 kilobases. The open reading frame is > 10,000 bases long, flanked by untranslated regions (UTR), and encodes a polyprotein that is co- and post-transcriptionally processed into three structural and seven non-structural proteins. Tick-borne encephalitis virus infection results in encephalitis, often with a characteristic biphasic disease course. After a short incubation time, the viraemic phase is characterised by non-specific influenza-like symptoms. After an asymptomatic period of 2-7 days, more than half of patients show progression to a neurological phase, usually characterised by central and, rarely, peripheral nervous system symptoms. Mortality is low-around 1% of confirmed cases, depending on the viral subtype. After acute tick-borne encephalitis (TBE), a minority of patients experience long-term neurological deficits. Additionally, 40%-50% of patients develop a post-encephalitic syndrome, which significantly impairs daily activities and quality of life. Although TBEV has been described for several decades, no specific treatment exists. Much remains unknown regarding the objective assessment of long-lasting sequelae. Additional research is needed to better understand, prevent, and treat TBE. In this review, we aim to provide a comprehensive overview of the epidemiology, virology, and clinical picture of TBE.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23016381
003      
CZ-PrNML
005      
20231026105939.0
007      
ta
008      
231013s2023 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1002/rmv.2470 $2 doi
035    __
$a (PubMed)37392370
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Chiffi, Gabriele $u Department for BioMedical Research, University of Bern, Bern, Switzerland $u Institute for Infectious Diseases, University of Bern, Bern, Switzerland $1 https://orcid.org/0009000227052479
245    10
$a Tick-borne encephalitis: A comprehensive review of the epidemiology, virology, and clinical picture / $c G. Chiffi, D. Grandgirard, SL. Leib, A. Chrdle, D. Růžek
520    9_
$a Tick-borne encephalitis virus (TBEV) is a flavivirus commonly found in at least 27 European and Asian countries. It is an emerging public health problem, with steadily increasing case numbers over recent decades. Tick-borne encephalitis virus affects between 10,000 and 15,000 patients annually. Infection occurs through the bite of an infected tick and, much less commonly, through infected milk consumption or aerosols. The TBEV genome comprises a positive-sense single-stranded RNA molecule of ∼11 kilobases. The open reading frame is > 10,000 bases long, flanked by untranslated regions (UTR), and encodes a polyprotein that is co- and post-transcriptionally processed into three structural and seven non-structural proteins. Tick-borne encephalitis virus infection results in encephalitis, often with a characteristic biphasic disease course. After a short incubation time, the viraemic phase is characterised by non-specific influenza-like symptoms. After an asymptomatic period of 2-7 days, more than half of patients show progression to a neurological phase, usually characterised by central and, rarely, peripheral nervous system symptoms. Mortality is low-around 1% of confirmed cases, depending on the viral subtype. After acute tick-borne encephalitis (TBE), a minority of patients experience long-term neurological deficits. Additionally, 40%-50% of patients develop a post-encephalitic syndrome, which significantly impairs daily activities and quality of life. Although TBEV has been described for several decades, no specific treatment exists. Much remains unknown regarding the objective assessment of long-lasting sequelae. Additional research is needed to better understand, prevent, and treat TBE. In this review, we aim to provide a comprehensive overview of the epidemiology, virology, and clinical picture of TBE.
650    _2
$a lidé $7 D006801
650    12
$a klíšťová encefalitida $x epidemiologie $x prevence a kontrola $7 D004675
650    _2
$a kvalita života $7 D011788
650    12
$a viry klíšťové encefalitidy $x genetika $7 D004669
650    _2
$a RNA $7 D012313
650    _2
$a veřejné zdravotnictví $7 D011634
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Grandgirard, Denis $u Institute for Infectious Diseases, University of Bern, Bern, Switzerland
700    1_
$a Leib, Stephen L $u Institute for Infectious Diseases, University of Bern, Bern, Switzerland
700    1_
$a Chrdle, Aleš $u Department of Infectious Diseases, Hospital Ceske Budejovice, Ceske Budejovice, Czech Republic $u Faculty of Health and Social Sciences, University of South Bohemia, Ceske Budejovice, Czech Republic $u Royal Liverpool University Hospital, Liverpool, UK
700    1_
$a Růžek, Daniel $u Veterinary Research Institute, Emerging Viral Diseases, Brno, Czech Republic $u Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic $u Institute of Parasitology, Biology Centre of the Czech Academy of Sciences, Ceske Budejovice, Czech Republic $1 https://orcid.org/0000000346552380 $7 stk2008441707
773    0_
$w MED00004118 $t Reviews in medical virology $x 1099-1654 $g Roč. 33, č. 5 (2023), s. e2470
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37392370 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20231013 $b ABA008
991    __
$a 20231026105933 $b ABA008
999    __
$a ok $b bmc $g 2000100 $s 1202743
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 33 $c 5 $d e2470 $e 20230701 $i 1099-1654 $m Reviews in medical virology $n Rev Med Virol $x MED00004118
LZP    __
$a Pubmed-20231013

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...